August 06, 2018 Almirall spots an opportunity The Spanish group shows again that there is a future in dermatology, but its Allergan deal really depends on the fate of one asset.
July 05, 2017 Biotech floats come back with a vengeance The biotech IPO market records its first billion dollar quarter in two years as demand for new issues recovers.
